Prevention of Menstrual Migraines: Effects of Continuous Oral Contraceptives to Combination With Prophylactic Frocvatriptan Use During Hormone Free Intervals
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2014
At a glance
- Drugs Frovatriptan (Primary)
- Indications Menstrual migraine
- Focus Therapeutic Use
- Acronyms MAM
- 22 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Dec 2009 Planned end date changed from 1 Aug 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.